(Health-NewsWire.Net, April 28, 2017 ) Publisher's clinical trial report, "Acute Pain Global Clinical Trials Review, H1, 2017" provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Publisher Clinical Trial Reports are generated using Publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report: http://www.reportsweb.com/acute-pain-global-clinical-trials-review-h1-2017 .
Report Scope
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001740907/sample .
Table of Contents
List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 14 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 20 Clinical Trials by Phase in E7 Countries 22 Clinical Trials in E7 Countries by Trial Status 23 Clinical Trials by Phase 25 In Progress Trials by Phase 26 Clinical Trials by Trial Status 27 Clinical Trials by End Point Status 29 Subjects Recruited Over a Period of Time 30 Clinical Trials by Sponsor Type 31 Prominent Sponsors 32 Top Companies Participating in Acute Pain Therapeutics Clinical Trials 34 Prominent Drugs 36 Latest Clinical Trials News on Acute Pain 37 Feb 21, 2017: Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain 37 Feb 13, 2017: AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA for Use in Burn Victims with Moderate-to-Severe Acute Pain 38 Jan 04, 2017: Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain 39 Dec 06, 2016: AcelRx Pharmaceuticals Reports on ARX-04 Market and Landscape Presented at Analyst & Investor Event 39 Nov 29, 2016: KemPharm Receives Clearance from FDA to Initiate Clinical Program for KP201/IR, a Single-Entity Benzhydrocodone HCl Immediate Release Abuse-Deterrent Prodrug for the Treatment of Acute Pain 40 Clinical Trial Profile Snapshots 41 Appendix 340 Abbreviations 340 Definitions 340 Research Methodology 341 Secondary Research 341 About Publisher 342 Contact Us 342 Disclaimer 342 Source 343
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001740907/buying .
Contact Us: Call: +1-646-491-9876 Email: sales@reportsweb.com
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|